INFLIXIMAB CLEARANCE PRE-THERAPY AND DURING INDUCTION PREDICTS LONG TERM DISEASE CONTROL IN INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Vermeire, Severine
D'Haens, Geert
Laharie, David
Dreesen, Erwin
Rabizadeh, Shervin
Jain, Anjali
Spencer, Elizabeth A.
Panetta, John C.
Dubinsky, Marla
Dervieux, Thierry
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
234
引用
收藏
页码：S45 / S46
页数：2
相关论文
共 50 条
  • [1] Infliximab trough levels for remission induction and long term therapy management of inflammatory bowel disease
    Perdigoto, D.
    Portela, F.
    Ferreira, M.
    Mendes, S.
    Freire, P.
    Ferreira, M.
    Lopes, S.
    Tome, L.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S386 - S386
  • [2] LONG-TERM SCHEDULED THERAPY WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE
    Armuzzi, A.
    Marzo, M.
    Felice, C.
    Mocci, G.
    De Vincentis, F.
    Andrisani, G.
    Pugliese, D.
    Fedeli, P.
    De Vitis, I.
    Papa, A.
    Gasbarrini, A.
    Guidi, L.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S88 - S88
  • [3] LONG-TERM SCHEDULED THERAPY WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE
    Armuzzi, A.
    De Vincentis, F.
    Marzo, M.
    De Pascalis, B.
    Roberto, I.
    Mocci, G.
    Fiore, F.
    Leso, V.
    Fedeli, P.
    Papa, A.
    De Vitis, I.
    Melina, D.
    Fedeli, G.
    Gasbarrini, A.
    Guidi, L.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S12 - S12
  • [4] Long-term scheduled therapy with infliximab in inflammatory bowel disease
    Armuzzi, Alessandro
    De pascalis, Barbara
    Roberto, Italia
    Ennas, Sara
    De vincentis, Fabio
    Guglielmo, Simona
    Fedeli, Paolo
    Papa, Alfredo
    De vitis, Italo
    Gasbarrini, Giovanni
    Melina, Domenico
    Fedeli, Giuseppe
    Gasbarrini, Antonio
    Guidi, Luisa
    GASTROENTEROLOGY, 2007, 132 (04) : A183 - A183
  • [5] Long-term scheduled therapy with infliximab in inflammatory bowel disease
    Armuzzi, A.
    De Vincentis, F.
    Marzo, M.
    De Pascalis, B.
    Roberto, I.
    Mocci, G.
    Fiore, F.
    Leso, V.
    Fedeli, P.
    Papa, A.
    De Vitis, I.
    Melina, D.
    Fedeli, G.
    Gasbarrini, A.
    Guidi, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2009, 13 : 84 - 84
  • [6] Long-Term Scheduled Therapy with Infliximab in Inflammatory Bowel Disease
    Armuzzi, Alessandro
    De Vincentis, Fabio
    Marzo, Manuela
    Mocci, Giammarco
    Felice, Carla
    Fedeli, Paolo
    De Vitis, Italo
    Papa, Alfredo
    Gasbarrini, Antonio
    Guidi, Luisa
    GASTROENTEROLOGY, 2009, 136 (05) : A663 - A663
  • [7] infliximab exposure during induction associate with time to remission and disease control of inflammatory bowel disease
    Laharie, D.
    Rabizadeh, S.
    D'Haens, G.
    Dubinsky, M.
    Panetta, J. C.
    Everts-van der Wind, A.
    Dreesen, E.
    Spencer, E.
    Vermeire, S.
    Dervieux, T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I335 - I335
  • [8] Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease
    van Hoeve, Karen
    Dreesen, Erwin
    Hoffman, Ilse
    Van Assche, Gert
    Ferrante, Marc
    Gils, Ann
    Vermeire, Severine
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2019, 68 (06): : 847 - 853
  • [9] Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel disease
    Vermeire, Severine
    Dubinsky, Marla C.
    Rabizadeh, Shervin
    Panetta, John C.
    Spencer, Elisabeth A.
    Dreesen, Erwin
    D'Haens, Geert
    Dervieux, Thierry
    Laharie, David
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (06)
  • [10] FORECASTED INFLIXIMAB CONCENTRATIONS DURING INDUCTION PREDICT TIME TO REMISSION AND SUSTAINED DISEASE CONTROL OF INFLAMMATORY BOWEL DISEASE
    Rabizadeh, Shervin
    D'Haens, Geert
    Dubinsky, Marla C.
    Panetta, John C.
    Everts-van der Wind, Annelie
    Dreesen, Erwin
    Spencer, Elizabeth A.
    Laharie, David
    Vermeire, Severine
    Dervieux, Thierry
    GASTROENTEROLOGY, 2023, 164 (06) : S1114 - S1114
12345